|
WO2021021674A1
|
|
Methods of treating hearing loss using a secreted target protein
|
|
WO2020097372A1
|
|
Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
|
|
WO2020097369A1
|
|
Compositions and methods of inducing differentiation of a hair cell
|
|
WO2020069320A1
|
|
A method for treating an auditory neuropathy spectrum disorder
|
|
AU2019300045A1
|
|
Methods of treating non-syndromic sensorineural hearing loss
|
|
AU2019294603A1
|
|
Methods of treating CLRN1-associated hearing loss and/or vision loss
|
|
CN112020561A
|
|
Compositions and methods for treating non-age-related hearing impairment in a human subject
|
|
CA3086045A1
|
|
Aav-mediated delivery of therapeutic antibodies to the inner ear
|
|
CN110225975A
|
|
For treating the composition and method of non-age-dependent hearing impairment in people experimenter
|
